|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.593
|
Human |
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.579
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.558
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.544
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.537
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.535
|
Human |
|
|
digestive system development
|
GO:0055123 |
200 |
0.530
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.489
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.466
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.466
|
Human |
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.452
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.446
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.430
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.426
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.409
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.405
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.387
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.356
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.329
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.302
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.301
|
Human |
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.279
|
Human |
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.261
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.258
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.256
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.255
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.246
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.240
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.236
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.234
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.229
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.222
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.210
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.210
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.206
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.205
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.203
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.201
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.195
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.192
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.190
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.188
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.188
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.185
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.179
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.170
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.166
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.165
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.162
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.161
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.159
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.157
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.155
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.150
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.147
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.147
|
Human |
|
|
camera type eye development
|
GO:0043010 |
266 |
0.147
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.147
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.145
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.143
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.140
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.140
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.140
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.137
|
|
|
|
translation
|
GO:0006412 |
93 |
0.134
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.132
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.130
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.130
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.129
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.125
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.125
|
|
|
|
external genitalia morphogenesis
|
GO:0035261 |
1 |
0.119
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.116
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.115
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.115
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.110
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.110
|
|
|
|
cerebellar purkinje cell layer morphogenesis
|
GO:0021692 |
14 |
0.108
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.107
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.107
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.105
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.101
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.101
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.100
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.100
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.099
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.098
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.097
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.097
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.096
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.095
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.093
|
|
|
|
positive regulation of histone deacetylation
|
GO:0031065 |
7 |
0.093
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.091
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.088
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.087
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.086
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.086
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.086
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.084
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.083
|
|
|
|
cerebellar purkinje cell layer development
|
GO:0021680 |
26 |
0.082
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.082
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.077
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.076
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.075
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.074
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.074
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.074
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.074
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.073
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.072
|
|
|
|
cerebellar purkinje cell differentiation
|
GO:0021702 |
13 |
0.072
|
|
|
|
type i pneumocyte differentiation
|
GO:0060509 |
7 |
0.072
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.072
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.072
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.071
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.071
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.069
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.069
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.069
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.068
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.068
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.068
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.067
|
|
|
|
histone h3 k9 trimethylation
|
GO:0036124 |
6 |
0.066
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.066
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.066
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.066
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.066
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.066
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.065
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.064
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.064
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.064
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.063
|
|
|
|
cerebellar granule cell differentiation
|
GO:0021707 |
9 |
0.062
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.062
|
|
|
|
posttranslational protein targeting to membrane
|
GO:0006620 |
2 |
0.061
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.061
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.061
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.061
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.061
|
Human |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.061
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.059
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.059
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.058
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.058
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.058
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.058
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.057
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.056
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.056
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.055
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.055
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.055
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.054
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.053
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.053
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.053
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.053
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.053
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.053
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.052
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.052
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.052
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.052
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.051
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.051
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.051
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.051
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.051
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.051
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.051
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.050
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.050
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.049
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.049
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
Human |
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.048
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.048
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.048
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.048
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.048
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.047
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.047
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.047
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.047
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.046
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.045
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.045
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.045
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.045
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.045
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.045
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.044
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.044
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.044
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.044
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.044
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.044
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.043
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.043
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.042
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.041
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.041
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.041
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.041
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.041
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.041
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.040
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.040
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.040
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.040
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.040
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.040
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.039
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.039
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.039
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.039
|
Human |
|
|
nuclear division
|
GO:0000280 |
158 |
0.039
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.039
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.039
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.039
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.039
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.039
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.039
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.038
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.038
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.038
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.038
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.037
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.037
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.037
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.037
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.036
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.036
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.036
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.036
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.036
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.036
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.035
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.035
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.035
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.035
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.035
|
|
|
|
regulation of n methyl d aspartate selective glutamate receptor activity
|
GO:2000310 |
10 |
0.035
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.035
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.034
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.034
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.034
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.033
|
|
|
|
regulation of gene silencing
|
GO:0060968 |
7 |
0.033
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.033
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.033
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.033
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.033
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.033
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.033
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.032
|
|
|
|
lung ciliated cell differentiation
|
GO:0061141 |
1 |
0.032
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.032
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.032
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.032
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.031
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.031
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.031
|
Human |
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.031
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.031
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
13 |
0.031
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.031
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.030
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.030
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.030
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.029
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.029
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.029
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.029
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.029
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.029
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.029
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.029
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.028
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.028
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.028
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.028
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.028
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.028
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.028
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.028
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.028
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.028
|
|
|
|
pteridine containing compound metabolic process
|
GO:0042558 |
5 |
0.027
|
|
|
|
macroautophagy
|
GO:0016236 |
21 |
0.027
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.027
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.027
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.027
|
|
|
|
regulation of anterior head development
|
GO:2000742 |
2 |
0.027
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.027
|
|
|
|
regulation of pancreatic juice secretion
|
GO:0090186 |
4 |
0.027
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.027
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.027
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.027
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.026
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.026
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.026
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.026
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.026
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.026
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.026
|
|
|
|
regulation of fear response
|
GO:1903365 |
2 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.025
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.025
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.025
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.025
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.025
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.025
|
Human |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.025
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.025
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.025
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.025
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.025
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.025
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.024
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.024
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.024
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.024
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.024
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.024
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.023
|
|
|
|
principal sensory nucleus of trigeminal nerve development
|
GO:0021740 |
2 |
0.023
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.023
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.023
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.023
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.023
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.023
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.022
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.022
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.022
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.022
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.022
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.022
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.022
|
Human |
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.022
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.021
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.021
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.021
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.021
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.021
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.021
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
|
regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000790 |
2 |
0.021
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.021
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.020
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.020
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.020
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.020
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.020
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.020
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.020
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.020
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.019
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.019
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.019
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.019
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.019
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.019
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.019
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.018
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.018
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
histone h4 deacetylation
|
GO:0070933 |
4 |
0.018
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.018
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.018
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.018
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.018
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.018
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.018
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.018
|
|
|
|
regulation of gene expression by genetic imprinting
|
GO:0006349 |
15 |
0.018
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.018
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.017
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.017
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.017
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.017
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.017
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.017
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.017
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.017
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.017
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.017
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.017
|
|
|
|
negative regulation of lymphocyte mediated immunity
|
GO:0002707 |
21 |
0.017
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.017
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.017
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.017
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.017
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.017
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.017
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.017
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.016
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.016
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.016
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.016
|
|
|
|
face development
|
GO:0060324 |
38 |
0.016
|
|
|
|
regulation of hepatocyte proliferation
|
GO:2000345 |
6 |
0.016
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.016
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.016
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.016
|
|
|
|
regulation of terminal button organization
|
GO:2000331 |
1 |
0.016
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.015
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.015
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.015
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.015
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.015
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.015
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.015
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.015
|
|
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.015
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.015
|
|
